Intelligence Platform
Patents
Browse 677 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 7026350
Water-soluble drugs and methods for their production
expired patentUS 7026291
Epithelial cell specific growth factor, keratinocyte growth factor (KGF)
expired patentUS 7025961
Anti-plasmodium composition and methods of use
expired patentUS 7015212
Thiazepine inhibitors of HIV-1 integrase
expired patentUS 7015024
Compositions containing recombinant poxviruses having foreign DNA expressed under the cont
expired patentUS 7015312
Antibodies to the protein product encoded by ORF3 of the TRP-1 gene and compositions and k
expired patentUS 7009050
5-Substituted pyrimidine derivatives of conformationally locked nucleoside analogues
expired patentUS 7009044
HCV/BVDV chimeric genomes and uses thereof
expired patentUS 7001614
Liposome complexes for increased systemic delivery
expired patentUS 6998252
Recombinant poxviruses having foreign DNA expressed under the control of poxvirus regulato
expired patentUS 6987096
Antiviral proteins and peptides, DNA coding sequences therefor, and uses thereof
expired patentUS 6984379
Gene therapy by administration of genetically engineered CD34+ cells obtained from cord bl
expired patentUS 6982168
Immortal human prostate epithelial cell lines and clones and their applications in the res
expired patentUS 6977241
SH2 domain binding inhibitors
expired patentUS 6977245
Oligodeoxynucleotide and its use to induce an immune response
expired patentUS 6974698
Methods for delivering biologically active molecules into cells
expired patentUS 6965017
Melanoma antigens and their use in diagnostic and therapeutic methods
expired patentUS 6962987
Binding domains from Plasmodium vivax and Plasmodium falciparum erythrocyte binding protei
expired patentUS 6958319
Formulation of boronic acid compounds
expired patentUS 6951917
MHC-class II restricted melanoma antigens and their use in therapeutic methods
expired patentUS 6951915
Redox-stable, non-phosphorylated cyclic peptide inhibitors of SH2 domain binding to target
expired patentUS 6949624
Cloning of the human nuclear receptor co-repressor gene
expired patentUS 6949530
Nitric oxide-releasing amidine diazeniumdiolates, compositions and uses thereof and method
expired patentUS 6946133
Prostate specific antigen oligo-epitope peptide
expired